SCOPUS 정보 검색 플랫폼

Volumn 21, Issue 5, 2013, Pages 1190-1198

Anticonvulsant evaluation of aminoalkanol derivatives of 2- and 4-methylxanthone

(7) Szkaradek, Natalia a Gunia, Agnieszka a Waszkielewicz, Anna M a Antkiewicz Michaluk, Lucyna b Cegła, Marek a Szneler, Edward c Marona, Henryk a

a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE (Poland)

b INSTITUTE OF PHARMACOLOGY (Poland)

c JAGIELLONIAN UNIVERSITY (Poland)

Author keywords

Anticonvulsant; MES; Neurotoxicity; Synthesis; Xanthone

Indexed keywords

2 ((1 HYDROXYBUTAN 2 YLAMINO)METHYL) 6 METHOXY 9H XANTHEN 9 ONE; 2 CHLORO 7 ((N (1 HYDROXY 2 METHYLPROPAN 2 YL)METHYLAMINO)METHYL) 9H XANTHEN 9 ONE; 2 CHLORO 7 (1 HYDROXY 2 METHYLPROPAN 2 YLAMINO)METHYL 9H XANTHEN 9 ONE; 2 CHLORO 7 (1 HYDROXYPROPAN 2 YLAMINO)METHYL 9H XANTHEN 9 ONE; 5 ((1 HYDROXY 2 METHYLPROPAN 2 YLAMINO)METHYL) 3 METHOXY 9H XANTHEN 9 ONE; 5 ((1 HYDROXYBUTAN 2 YLAMINO)METHYL) 3 METHOXY 9H XANTHEN 9 ONE; 5 ((1 HYDROXYPROPAN 2 YLAMINO)METHYL) 3 METHOXY 9H XANTHEN 9 ONE; 5 ((2 HYDROXYPROPAN 2 YLAMINO)METHYL) 3 METHOXY 9H XANTHEN 9 ONE; 5 ((N (1 HYDROXYBUTAN 2 YL)METHYLAMINO)METHYL) 3 METHOXY 9H XANTHEN 9 ONE; 6 METHOXY 4 METHYLXANTHONE; 7 CHLORO 2 METHYLXANTHONE; PENTETRAZOLE; UNCLASSIFIED DRUG; VALPROIC ACID; XANTHONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SYNTHESIS; ELECTRIC SHOCK; IN VITRO STUDY; MOUSE; NEUROTOXICITY; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PHARMACOPHORE; RAT; SEIZURE; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; TD 50;

ANIMALS; ANTICONVULSANTS; CALCIUM CHANNELS; ELECTROSHOCK; INJECTIONS, INTRAPERITONEAL; MICE; NEURONS; PENTYLENETETRAZOLE; SEIZURES; STRUCTURE-ACTIVITY RELATIONSHIP; XANTHONES;

MUS;

EID: 84873713237 PISSN: 09680896 EISSN: 14643391 Source Type: Journal
DOI: 10.1016/j.bmc.2012.12.051 Document Type: Article

Times cited : (20)

References (28)

1
- 77951590218
- A.K. Ngugi, C. Bottomley, I. Kleinschmidt, J.W. Sander, and C.R. Newton Epilepsia 62 2010 883
- (2010) Epilepsia , vol.62 , pp. 883
- Ngugi, A.K.¹ Bottomley, C.² Kleinschmidt, I.³ Sander, J.W.⁴ Newton, C.R.⁵

2
- 80052592003
- P. Kwan, S.C. Schachter, and M.J. Brodie N. Eng. J. Med. 365 2011 919
- (2011) N. Eng. J. Med. , vol.365 , pp. 919
- Kwan, P.¹ Schachter, S.C.² Brodie, M.J.³

3
- 34547828792
- E. Perucca, J. French, and M. Bialer Lancet Neurol. 6 2007 793
- (2007) Lancet Neurol. , vol.6 , pp. 793
- Perucca, E.¹ French, J.² Bialer, M.³

4
- 0034864170
- H. Kupferberg Epilepsia 4 2001 7
- (2001) Epilepsia , vol.4 , pp. 7
- Kupferberg, H.¹

5
- 0014295117
- P. Da Re, V. Mancini, E. Tòth, and L. Cima Arzneimittelforschung 18 1968 718
- (1968) Arzneimittelforschung , vol.18 , pp. 718
- Da Re, P.¹ Mancini, V.² Tòth, E.³ Cima, L.⁴

6
- 0015418325
- J.R. Pflister, R.W. Ferraresi, I.T. Harrison, W.H. Rooks, A.P. Roszkowski, A. Van Horn, and J.H. Fried J. Med. Chem. 15 1972 1032
- (1972) J. Med. Chem. , vol.15 , pp. 1032
- Pflister, J.R.¹ Ferraresi, R.W.² Harrison, I.T.³ Rooks, W.H.⁴ Roszkowski, A.P.⁵ Van Horn, A.⁶ Fried, J.H.⁷

7
- 0020072861
- R.M. Gion, P. Valenti, P. Montanasi, and P. Da Re Arzneimittelforschung 32 1982 499
- (1982) Arzneimittelforschung , vol.32 , pp. 499
- Gion, R.M.¹ Valenti, P.² Montanasi, P.³ Da Re, P.⁴

8
- 0025003392
- H. Sato, T. Dan, E. Onuma, H. Tanaka, and H. Koga Chem. Pharm. Bull. 38 1990 1266
- (1990) Chem. Pharm. Bull. , vol.38 , pp. 1266
- Sato, H.¹ Dan, T.² Onuma, E.³ Tanaka, H.⁴ Koga, H.⁵

9
- 0024605005
- G.W. Rewcastle, G.J. Atwell, B.C. Baguley, S.B. Calveley, and W.A. Denny J. Med. Chem. 32 1989 793
- (1989) J. Med. Chem. , vol.32 , pp. 793
- Rewcastle, G.W.¹ Atwell, G.J.² Baguley, B.C.³ Calveley, S.B.⁴ Denny, W.A.⁵

10
- 0036501116
- S. Moreau, M. Varache-Lembège, S. Larrouture, D. Fall, A. Neveu, G. Deffieux, J. Vercauteren, and A. Nuhrich Eur. J. Med. Chem. 37 2002 237
- (2002) Eur. J. Med. Chem. , vol.37 , pp. 237
- Moreau, S.¹ Varache-Lembège, M.² Larrouture, S.³ Fall, D.⁴ Neveu, A.⁵ Deffieux, G.⁶ Vercauteren, J.⁷ Nuhrich, A.⁸

11
- 0033617992
- S. Mari, M. Rossi, P. Valenti, and P. Da Re Farmaco 54 1999 411
- (1999) Farmaco , vol.54 , pp. 411
- Mari, S.¹ Rossi, M.² Valenti, P.³ Da Re, P.⁴

12
- 58549111061
- H. Marona, N. Szkaradek, E. Karczewska, D. Trojanowska, A. Budak, P. Bober, W. Przepiórka, M. Cegła, and E. Szneler Arch. Pharm. Chem. Life Sci. 342 2009 9
- (2009) Arch. Pharm. Chem. Life Sci. , vol.342 , pp. 9
- Marona, H.¹ Szkaradek, N.² Karczewska, E.³ Trojanowska, D.⁴ Budak, A.⁵ Bober, P.⁶ Przepiórka, W.⁷ Cegła, M.⁸ Szneler, E.⁹

13
- 58949100278
- H. Marona, N. Szkaradek, A. Rapacz, B. Filipek, M. Dybała, A. Siwek, M. Cegła, and E. Szneler Bioorg. Med. Chem. 17 2009 1345
- (2009) Bioorg. Med. Chem. , vol.17 , pp. 1345
- Marona, H.¹ Szkaradek, N.² Rapacz, A.³ Filipek, B.⁴ Dybała, M.⁵ Siwek, A.⁶ Cegła, M.⁷ Szneler, E.⁸

14
- 0031745318
- H. Marona Pharmazie 53 1998 405
- (1998) Pharmazie , vol.53 , pp. 405
- Marona, H.¹

15
- 0031668466
- H. Marona Pharmazie 53 1998 672
- (1998) Pharmazie , vol.53 , pp. 672
- Marona, H.¹

16
- 2642611955
- H. Marona, Z. Górka, and E. Szneler Pharmazie 53 1998 219
- (1998) Pharmazie , vol.53 , pp. 219
- Marona, H.¹ Górka, Z.² Szneler, E.³

17
- 20544459128
- T. Librowski, R. Czarnecki, M. Jastrzebska-Wiesek, W. Opoka, and H. Marona Boll. Chim. Farm. 143 2004 267
- (2004) Boll. Chim. Farm. , vol.143 , pp. 267
- Librowski, T.¹ Czarnecki, R.² Jastrzebska-Wiesek, M.³ Opoka, W.⁴ Marona, H.⁵

18
- 84979185819
- F. Ullmann, and H. Kipper Ber. Dtsch. Chem. Ges. 38 1905 2120
- (1905) Ber. Dtsch. Chem. Ges. , vol.38 , pp. 2120
- Ullmann, F.¹ Kipper, H.²

19
- 84942707712
- A.A. Moroz, and M.S. Shvartsberg Russ. Chem. Rev. 43 1974 1443
- (1974) Russ. Chem. Rev. , vol.43 , pp. 1443
- Moroz, A.A.¹ Shvartsberg, M.S.²

20
- 48449106288
- H. Marona, E. Pȩkala, L. Antkiewicz-Michaluk, M. Walczak, and E. Szneler Bioorg. Med. Chem. 16 2008 7234
- (2008) Bioorg. Med. Chem. , vol.16 , pp. 7234
- Marona, H.¹ Pȩkala, E.² Antkiewicz-Michaluk, L.³ Walczak, M.⁴ Szneler, E.⁵

21
- 0004010895
- G. Avanzini, P. Tanganelli, M. Avoli, John Libey & Co London
- J.P. Stables, and H.J. Kupferberg G. Avanzini, P. Tanganelli, M. Avoli, Molecular and Cellular Targets for Antiepileptic Drugs 1997 John Libey & Co London 191 198
- (1997) Molecular and Cellular Targets for Antiepileptic Drugs , pp. 191-198
- Stables, J.P.¹ Kupferberg, H.J.²

22
- 0004203209
- R.H. Levy, R.H. Mattson, B.S. Meldrum, E. Perucca, 5th ed. Lippincott Williams & Wilkins Philadelphia
- H.S. White, J.H. Woodhead, K.S. Wilcox, J.P. Stables, H.J. Kupferberg, and H.H.D. Wolf R.H. Levy, R.H. Mattson, B.S. Meldrum, E. Perucca, Antiepileptic Drugs 5th ed. 2002 Lippincott Williams & Wilkins Philadelphia 36 48
- (2002) Antiepileptic Drugs , pp. 36-48
- White, H.S.¹ Woodhead, J.H.² Wilcox, K.S.³ Stables, J.P.⁴ Kupferberg, H.J.⁵ Wolf, H.H.D.⁶

23
- 0042416551
- H.S. White Epilepsia 44 2003 2
- (2003) Epilepsia , vol.44 , pp. 2
- White, H.S.¹

24
- 0345062254
- G. Rajtar, D. Zółkowska, Z. Kleinrok, and H. Marona Acta Pol. Pharm. Drug Res. 56 1999 311
- (1999) Acta Pol. Pharm. Drug Res. , vol.56 , pp. 311
- Rajtar, G.¹ Zółkowska, D.² Kleinrok, Z.³ Marona, H.⁴

25
- 56849089954
- M. Jastrzȩbska-Wiȩsek, R. Czarnecki, and H. Marona Acta Pol. Pharm. Drug Res. 65 2008 591
- (2008) Acta Pol. Pharm. Drug Res. , vol.65 , pp. 591
- Jastrzȩbska-Wiȩsek, M.¹ Czarnecki, R.² Marona, H.³

26
- 0000397013
- W.C. Brown, D.O. Schiffman, E.A. Swinyard, and L.S. Goodman J. Pharmacol. Exp. Ther. 107 1953 273
- (1953) J. Pharmacol. Exp. Ther. , vol.107 , pp. 273
- Brown, W.C.¹ Schiffman, D.O.² Swinyard, E.A.³ Goodman, L.S.⁴

27
- 0035652290
- M. Barton Epilepsy Res. 47 2001 217
- (2001) Epilepsy Res. , vol.47 , pp. 217
- Barton, M.¹

28
- 3042816099
- R.M. Kamiński, M.R. Livingood, and M. Rogawski Epilepsia 45 2004 864
- (2004) Epilepsia , vol.45 , pp. 864
- Kamiński, R.M.¹ Livingood, M.R.² Rogawski, M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.